Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Appointed director
|
|
NEUROCRINE BIOSCIENCES INC (NBIX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/11/2023 |
4/A
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC |
| 05/11/2023 |
4/A
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC |
| 05/11/2023 |
4/A
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC |
| 05/03/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/26/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/29/2021 |
4/A
| ROBERTS EIRY (Chief Medical Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 49,049 options
@ $117.63, valued at
$5.8M
|
|
| 03/29/2021 |
4/A
| Lloyd-Smith Malcolm (Chief Regulatory Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 35,035 options
@ $117.63, valued at
$4.1M
|
|
| 03/29/2021 |
4/A
| Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 45,546 options
@ $117.63, valued at
$5.4M
|
|
| 03/29/2021 |
4/A
| Grigoriadis Dimitri E. (Chief Research Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 42,042 options
@ $117.63, valued at
$4.9M
|
|
| 03/29/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/29/2021 |
4/A
| Gano Kyle (Chief Business Development Off) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 49,049 options
@ $117.63, valued at
$5.8M
|
|
| 03/29/2021 |
4/A
| Cooke Julie (Chief Human Resources Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 35,035 options
@ $117.63, valued at
$4.1M
|
|
| 03/29/2021 |
4/A
| Bozigian Haig P. (Chief Development Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 3,504 options
@ $117.43, valued at
$411.5k
|
|
| 03/26/2021 |
4/A
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 49,049 options
@ $117.63, valued at
$5.8M
|
|
| 03/26/2021 |
4/A
| ABERNETHY MATT (CFO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 49,049 options
@ $117.63, valued at
$5.8M
|
|
| 05/24/2016 |
4/A
| POPS RICHARD F (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 25,000 options to buy
@ $42.76, valued at
$1.1M
|
|
| 05/24/2016 |
4/A
| RASTETTER WILLIAM H (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 30,000 options to buy
@ $42.76, valued at
$1.3M
|
|
| 05/24/2016 |
4/A
| MOLLICA JOSEPH A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 25,000 options to buy
@ $42.76, valued at
$1.1M
|
|
| 05/24/2016 |
4/A
| MITCHELL W THOMAS (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 25,000 options to buy
@ $42.76, valued at
$1.1M
Granted 25,000 options to buy
@ $42.76, valued at
$1.1M
|
|
| 05/24/2016 |
4/A
| Nevinny Corinne H (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 25,000 options to buy
@ $42.76, valued at
$1.1M
Granted 25,000 options to buy
@ $42.76, valued at
$1.1M
|
|
|
|